Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting

Background: Most hospitals still use unfractionated heparin (UFH) as the primary agent for venous thromboembolism (VTE) prophylaxis in the hospital setting due to ease of use and insignificant cost. However, the risk of heparin-induced thrombocytopenia (HIT) has led some groups to favor other option...

Full description

Bibliographic Details
Main Authors: Harry Menon, Adip Pillai, Jeanine Aussenberg-Rodriguez, John Ambrose, Irini Youssef, Elizabeth G Griffiths, Omar Al Ustwani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-10-01
Series:Avicenna Journal of Medicine
Subjects:
anticoagulation
heparin-induced thrombocytopenia
low molecular weight heparin
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.AJM_78_18

Internet

http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.AJM_78_18

Similar Items